Facial nerve hemangioma accounts for 0.7% of all intratemporal tumors.' It can arise from any segment of the facial nerve. Facial nerve hemangioma occurs at three sites; in decreasing order of frequency, they are the geniculate region, the distal internal auditory canal, and the mastoid segmen t at the departure of the chorda tympani nerve.'
Facial nerve hemangioma of the middle ear
Issam Saliba, MD; Jose N . Fayad, MD Facial nerve hemangioma accounts for 0.7% of all intratemporal tumors.' It can arise from any segment of the facial nerve. Facial nerve hemangioma occurs at three sites; in decreasing order of frequency, they are the geniculate region, the distal internal auditory canal, and the mastoid segmen t at the departure of the chorda tympani nerve. ' We evaluated a 39-year-old woman who had presented with a 2-year history of progressive rightsided facial weakness (House-Brackman n grade V). Examination detected a reddish-blue vascul ar mass behind the tympanic membrane that filled the posterosuperior part of the right tympanic cavit y (figure 1). Audiometry documented a mild conductive hearing loss on the right. High-resolut ion computed tomography (CT) demonstrated an 18 x 5.6-mm lesion at the posterior genu of the facial nerve that obliterated the oval win dow (figure 2, A). Th is lesion featured discrete intratumoral bony spicules that had a honeycomb appearance. Magnetic resonance imaging (MRI) documented a bright enhancement with gadolinium on Tl -weighted imaging (figur e 2, B).
The tumor was excised via a transmastoid/transtympanic approach. Separation of the nerve from the tumor was not feasible, so the tumor was removed together with the facial nerve genu. Following tumor removal, the continuity of the facial nerve was restored with a sural nerve graft. Histopathologic studies confirmed the diagnosis of a hemangioma. At 14 months postoperatively, the patient's facial function had improved to House-Brackmann grade III.
Despite the rarity of facial nerve hemangiomas, the presence of a facial ner ve function deficit-especially
Fi gure 1. Otoscopy shows the reddish-blue vascular mass behind the tympanic membrane.
if it is progressive, persistent, or recurrent-should always arouse suspicion of a facial nerve lesion. The clinical features of facial ner ve hemangiomas dep end on the site of origin. The differential diagnosis includes a variety of lesions, including vascular (high jugular bulb and an uncovered or aberra nt intratympanic internal carotid artery) ; neoplastic (glomus jugulare, glomus tympanicum, hemangioma, men ingioma, neuroma, and others such as rhabdomyosarcom a, leukemia, histiocyto sis X); and inflammatory (cholestero l granuloma and aura l pol yp ) lesions .' On the basis of this large list of possibilities, a definitive diagnosis can be established onl y by histologic examination.
Figure2. A: CT shows the lesion (arrow) at theposteriorgenu of the[acial nerve. B: MRI demonstrates the bright enhancement (arroIV)
with gadolinium 011 Tl-weighted imaging.
The cho ice of surg ical approach to a facial nerve hem angiom a depend s on th e location of th e tumor, th e preoperative hearing level, and the size of the tumor. Generally, the goals of tre atment are to completely remove the tumor and to attempt to preserve or restore facial nerve function an d hearing.
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